View Exam | PowerPak

1. BP is a patient with a newly diagnosed metastatic GIST, which is found to be positive for the KIT exon 9 mutation. Which of the following is an appropriate therapy for BP?

A. Imatinib 400 mg daily B. Sunitinib 50 mg daily C. Imatinib 800 mg daily D. Ripretinib 160 mg daily E. Unsure

2. Which of the following monitoring parameters is common to all current targeted GIST therapies?

A. Thyroid function tests B. Liver function tests C. Cognitive dysfunction D. Assessment for new blood clots E. Unsure

3. Gastrointestinal stromal tumors are most commonly found

A. In pediatric patients B. In the small bowel C. Outside of the bowel D. In the stomach E. Unsure

4. When addressing behavioral adherence concerns with a patient about to begin GIST therapy it is important to focus on

A. Daily habits, which will help choose the best administration time B. Whether they have a pill splitter available to reduce the pill size C. If their prescription copay was paid by an assistance plan D. If they need assistance with reading prescription bottle labels E. Unsure

Evaluation Questions

5. How confident are you in your treatment of BP in the post-test?

A. Not at all confident B. Somewhat confident C. Confident D. Highly confident

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. BP is a patient with a newly diagnosed metastatic GIST, which is found to be positive for the KIT exon 9 mutation. Which of the following is an appropriate therapy for BP?

2. Which of the following monitoring parameters is common to all current targeted GIST therapies?

3. Gastrointestinal stromal tumors are most commonly found

4. When addressing behavioral adherence concerns with a patient about to begin GIST therapy it is important to focus on

Evaluation Questions

5. How confident are you in your treatment of BP in the post-test?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. BP is a patient with a newly diagnosed metastatic GIST, which is found to be positive for the KIT exon 9 mutation. Which of the following is an appropriate therapy for BP?

2. Which of the following monitoring parameters is common to all current targeted GIST therapies?

3. Gastrointestinal stromal tumors are most commonly found

4. When addressing behavioral adherence concerns with a patient about to begin GIST therapy it is important to focus on

Evaluation Questions

5. How confident are you in your treatment of BP in the post-test?

« Return to Activity

Customers who Purchased
this Activity also Purchased